Abstract
Purpose: To assess the safety and feasibility of HoLEP as a day-case procedure. Methods: We reviewed all consecutive patients who underwent HoLEP at our institution between February 2017 and March 2018. During this time, we began a prospective trial aimed at same-day discharge of specific patients. Baseline and demographic variables, and past medical, past urological, intra-operative and post-operative variables in addition to disposition and readmission data were collected. Bivariate analysis was conducted to compare patients based on the day of discharge and readmission. A multivariable model using multiple-regression analysis was used to assess predictors for early discharge or readmission. Results: There were 179 total HoLEP procedures that were performed during the study period. Forty-seven patients were suitable candidates for same-day discharge. Among this group, 28 (59.5%) patients were successfully discharged home on the same day. Nineteen patients (40.4%) could not be discharged. The most common cause of not to discharge patients was the degree of hematuria without continuous bladder irrigation. Pre-operative prostate volume was different between the two groups (88.4 ± 30.7 cc for discharged patients vs 69.0 ± 30.7 cc for admitted patients, p = 0.033). No other pre-operative differences were identified. There were five readmissions (17.8%) following same-day discharge. Readmitted patients had higher rates of history of urinary tract infection (80% vs 26.2%, p = 0.0304). On multivariable analysis, no statistically significant predictors were identified for early discharge or readmission. Conclusions: Same-day discharge following HoLEP is safe and feasible in well-selected patients.
| Original language | English (US) |
|---|---|
| Journal | World Journal of Urology |
| DOIs | |
| State | Published - Jan 1 2019 |
Fingerprint
Keywords
- BPH
- HoLEP
- Holmium
- Prostate
- Same day surgery
ASJC Scopus subject areas
- Urology
Cite this
Feasibility of holmium laser enucleation of the prostate as a 1-day surgery. / Abdul-Muhsin, Haidar; Critchlow, William; Navaratnam, Anojan; Gnecco, James; Tay, Kimberly; Girardo, Marlene; Andrews, Paul; Cheney, Scott; Humphreys, Mitchell R.
In: World Journal of Urology, 01.01.2019.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Feasibility of holmium laser enucleation of the prostate as a 1-day surgery
AU - Abdul-Muhsin, Haidar
AU - Critchlow, William
AU - Navaratnam, Anojan
AU - Gnecco, James
AU - Tay, Kimberly
AU - Girardo, Marlene
AU - Andrews, Paul
AU - Cheney, Scott
AU - Humphreys, Mitchell R
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Purpose: To assess the safety and feasibility of HoLEP as a day-case procedure. Methods: We reviewed all consecutive patients who underwent HoLEP at our institution between February 2017 and March 2018. During this time, we began a prospective trial aimed at same-day discharge of specific patients. Baseline and demographic variables, and past medical, past urological, intra-operative and post-operative variables in addition to disposition and readmission data were collected. Bivariate analysis was conducted to compare patients based on the day of discharge and readmission. A multivariable model using multiple-regression analysis was used to assess predictors for early discharge or readmission. Results: There were 179 total HoLEP procedures that were performed during the study period. Forty-seven patients were suitable candidates for same-day discharge. Among this group, 28 (59.5%) patients were successfully discharged home on the same day. Nineteen patients (40.4%) could not be discharged. The most common cause of not to discharge patients was the degree of hematuria without continuous bladder irrigation. Pre-operative prostate volume was different between the two groups (88.4 ± 30.7 cc for discharged patients vs 69.0 ± 30.7 cc for admitted patients, p = 0.033). No other pre-operative differences were identified. There were five readmissions (17.8%) following same-day discharge. Readmitted patients had higher rates of history of urinary tract infection (80% vs 26.2%, p = 0.0304). On multivariable analysis, no statistically significant predictors were identified for early discharge or readmission. Conclusions: Same-day discharge following HoLEP is safe and feasible in well-selected patients.
AB - Purpose: To assess the safety and feasibility of HoLEP as a day-case procedure. Methods: We reviewed all consecutive patients who underwent HoLEP at our institution between February 2017 and March 2018. During this time, we began a prospective trial aimed at same-day discharge of specific patients. Baseline and demographic variables, and past medical, past urological, intra-operative and post-operative variables in addition to disposition and readmission data were collected. Bivariate analysis was conducted to compare patients based on the day of discharge and readmission. A multivariable model using multiple-regression analysis was used to assess predictors for early discharge or readmission. Results: There were 179 total HoLEP procedures that were performed during the study period. Forty-seven patients were suitable candidates for same-day discharge. Among this group, 28 (59.5%) patients were successfully discharged home on the same day. Nineteen patients (40.4%) could not be discharged. The most common cause of not to discharge patients was the degree of hematuria without continuous bladder irrigation. Pre-operative prostate volume was different between the two groups (88.4 ± 30.7 cc for discharged patients vs 69.0 ± 30.7 cc for admitted patients, p = 0.033). No other pre-operative differences were identified. There were five readmissions (17.8%) following same-day discharge. Readmitted patients had higher rates of history of urinary tract infection (80% vs 26.2%, p = 0.0304). On multivariable analysis, no statistically significant predictors were identified for early discharge or readmission. Conclusions: Same-day discharge following HoLEP is safe and feasible in well-selected patients.
KW - BPH
KW - HoLEP
KW - Holmium
KW - Prostate
KW - Same day surgery
UR - http://www.scopus.com/inward/record.url?scp=85067649722&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067649722&partnerID=8YFLogxK
U2 - 10.1007/s00345-019-02831-6
DO - 10.1007/s00345-019-02831-6
M3 - Article
AN - SCOPUS:85067649722
JO - World Journal of Urology
JF - World Journal of Urology
SN - 0724-4983
ER -